1.
Journal of Medical Postgraduates
;
(12): 443-448, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-818258
RESUMO
Clopidogrel exhibits variable individual pharmacokinetic, and clopidogrel resistance may occur in some patients which can’t obtain effective platelet inhibition. To prevent the occurrence of cardiovascular adverse events and improve the clinical curative effect, the article explicated and analyzed relevant guidelines and the latest research of clopidogrel detailedly, summarized an individual dose recommendation in pharmacogenomics for the rational use of clopidogrel.